Search results for "Targeted Cancer Drugs"

Korean Researchers Uncover New Clues to Enhance Chronic Myeloid Leukemia Treatment

Korean Researchers Uncover New Clues to Enhance Chronic Myeloid Leukemia Treatment

Korean researchers have uncovered a biological mechanism that could significantly improve the efficacy of treatments for chronic myeloid leukemia .
Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment

Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment

Hanmi Pharmaceutical has unveiled a next-generation cancer technology designed to deliver drugs to the tumor microenvironment surrounding cancer...
Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters

Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters

Lung cancer is the second most commonly diagnosed cancer in South Korea and the leading cause of cancer mortality,...
To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why

To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why

As the adoption of GLP-1 receptor agonist obesity medications such as Wegovy and Mounjaro accelerates, medical experts...
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells

Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells

South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits

Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits

Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct...
Why Stage 3 Breast Cancer Doesn’t Always Mean Immediate Surgery

Why Stage 3 Breast Cancer Doesn’t Always Mean Immediate Surgery

“Shouldn’t it be removed as soon as possible — even a day sooner?” This reaction is common among patients and their...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors

Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment

For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...